Karyotype and prognosis in childhood acute lymphoblastic leukemia (ALL) in the UK medical research council (MRC) ALL97 trial.

Karyotype and prognosis in childhood acute lymphoblastic leukemia (ALL) in the UK medical research council (MRC) ALL97 trial.

Библиографические подробности
Главные авторы:	Moorman, A, Richards, S, Martineau, M, Cheung, K, Robinson, H, Jalali, G, Broadfield, Z, Harris, R, Barber, K, Lilleyman, J, Kinsey, S, Eden, O, Vora, A, Mitchell, C, Harrison, C
Формат:	Conference item
Опубликовано:	2003

Схожие документы

Variables affecting kinetics of minimal residual disease clearance in children with lymphoblastic leukaemia; Results of the United Kingdom Medical Research Council (UK MRC) protocols ALL97, ALL97/99 and ALL2003.
по: Vora, A, и др.
Опубликовано: (2005)

Thioguanine-related veno-occlusive disease (VOD) of the liver in children with acute lymphoblastic leukaemia (ALL): Report from United Kingdom Medical Research Council (UK MRC) trial ALL97.
по: Vora, A, и др.
Опубликовано: (2002)

Benefit of intensified treatment for all children with acute lymphoblastic leukaemia: results from MRC UKALL XI and MRC ALL97 randomised trials. UK Medical Research Council's Working Party on Childhood Leukaemia.
по: Hann, I, и др.
Опубликовано: (2000)

Benefit of targeted intensification for NCI high risk childhood lymphoblastic leukaemia: Results of the United Kingdom medical research council trial ALL97 and ALL97/99.
по: Vora, A, и др.
Опубликовано: (2006)

MRC ALL97/99 - A randomized comparison of dexamethasone versus prednisolone and thioguanine versus mercaptopurine in the treatment of childhood acute lymphoblastic leukemia.
по: Mitchell, C, и др.
Опубликовано: (2002)

Benefit of dexamethasone compared with prednisolone for childhood acute lymphoblastic leukaemia: results of the UK Medical Research Council ALL97 randomized trial.
по: Mitchell, C, и др.
Опубликовано: (2005)

TEL-AML1 fusion in childhood acute lymphoblastic leukaemia (ALL): Demographics, clinical features, cytogenetic characteristics and prognosis
по: Moorman, A, и др.
Опубликовано: (2005)

Thioguanine compared with mercaptopurine in childhood lymphoblastic leukaemia: Results of the United Kingdom medical research council randomised trial ALL97.
по: Lennard, L, и др.
Опубликовано: (2005)

Prognostic Relevance of Cytogenetics in Childhood Acute Lymphoblastic Leukaemia (ALL): Final Results From MRC ALL97.
по: Moor-Man, A, и др.
Опубликовано: (2009)

Prognosis of children with acute lymphoblastic leukemia (ALL) and intrachromosomal amplification of chromosome 21 (iAMP21).
по: Moorman, A, и др.
Опубликовано: (2007)

The impact of risk stratification by early bone-marrow response in childhood lymphoblastic leukaemia: results from the United Kingdom Medical Research Council trial ALL97 and ALL97/99.
по: Mitchell, C, и др.
Опубликовано: (2009)

Three distinct subgroups of hypodiploidy in acute lymphoblastic leukemia in UK MRC trials.
по: Harrison, C, и др.
Опубликовано: (2003)

Demographic, clinical, and outcome features of children with acute lymphoblastic leukemia and CRLF2 deregulation: results from the MRC ALL97 clinical trial.
по: Ensor, H, и др.
Опубликовано: (2011)

Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial.
по: Moorman, A, и др.
Опубликовано: (2007)

Acute lymphoblastic leukaemia has a poor outcome in children with Down syndrome due to infective death in remission - (Results of UK MRC ALL 97 trial).
по: de la Fuente, J, и др.
Опубликовано: (2005)

The clinical pharmacology of thioguanine vs. mercaptopurine in ALL97, a randomized trial for the treatment of childhood lymphoblastic leukaemia
по: Lennard, L, и др.
Опубликовано: (2008)

Prognostic effect of chromosomal abnormalities in childhood B-cell precursor acute lymphoblastic leukaemia: results from the UK Medical Research Council ALL97/99 randomised trial.
по: Moorman, A, и др.
Опубликовано: (2010)

Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia
по: Moorman, A, и др.
Опубликовано: (2007)

Outcome heterogeneity in childhood high-hyperdiploid acute lymphoblastic leukemia.
по: Moorman, A, и др.
Опубликовано: (2003)

Testicular irradiation in childhood lymphoblastic leukaemia. Medical Research Council Working Party on Leukemia in Childhoods.
по: Eden, O, и др.
Опубликовано: (1990)

Risk-directed treatment intensification significantly reduces the risk of relapse among children and adolescents with acute lymphoblastic leukemia and intrachromosomal amplification of chromosome 21: a comparison of the MRC ALL97/99 and UKALL2003 trials.
по: Moorman, A, и др.
Опубликовано: (2013)

The thiopurine methyltransferase TPMT *1/*3A genotype is associated with a better treatment outcome in the UK ALL97 trial for childhood acute lymphoblastic leukaemia; TPMT heterozygosity is not associated with secondary cancers
по: Lennard, L, и др.
Опубликовано: (2010)

Clinical significance of blast cell karyotype change at relapse of childhood ALL.
по: Vora, A, и др.
Опубликовано: (1996)

Thioguanine versus mercaptopurine in ALL97: thiopurine metabolism and treatment outcome
по: Lennard, L, и др.
Опубликовано: (2008)

Karyotype is an independent prognostic factor in adult acute lymphoblastic leukaemia (ALL): Analysis of cytogenetic data from 1,235 patients on the medical research council (MRC) UKALLXII/Eastern cooperative oncology group (ECOG) 2993 trial.
по: Moorman, A, и др.
Опубликовано: (2005)

A third intensive block of treatment at 35 weeks improves outcome in childhood ALL: Preliminary results from the UKALLXI and ALL97 randomised trials.
по: Richards, S, и др.
Опубликовано: (1998)

Late relapsing childhood lymphoblastic leukemia.
по: Vora, A, и др.
Опубликовано: (1998)

Improved Outcome for Children and Young Adults with T-Cell Acute Lymphoblastic Leukaemia (ALL): Results of the United Kingdom Medical Research Council (MRC) Trial UKALL 2003
по: Vora, A, и др.
Опубликовано: (2008)

Acute lymphoblastic leukaemia in infancy: experience in MRC UKALL trials. Report from the Medical Research Council Working Party on Childhood Leukaemia.
по: Chessells, J, и др.
Опубликовано: (1994)

Amplification of AML1 in acute lymphoblastic leukemia is associated with a poor outcome.
по: Robinson, H, и др.
Опубликовано: (2003)

Three distinct subgroups of hypodiploidy in acute lymphoblastic leukaemia.
по: Harrison, C, и др.
Опубликовано: (2004)

Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study.
по: Fielding, A, и др.
Опубликовано: (2007)

Intraocular relapse of childhood acute lymphoblastic leukemia.
по: Somervaille, T, и др.
Опубликовано: (2002)

Karyotype is an independent prognostic factor in adult acute lymphoblastic leukaemia
по: Moorman, A, и др.
Опубликовано: (2007)

Gender and treatment outcome in childhood lymphoblastic leukaemia: report from the MRC UKALL trials.
по: Chessells, J, и др.
Опубликовано: (1995)

Induction therapy for adults with acute lymphoblastic leukemia (ALL): Results of nearly 1,400 patients from the international ALL trial (MRC UKALL XII/ECOG E2993).
по: Rowe, J, и др.
Опубликовано: (2003)

Cytogenetics and prognosis in childhood lymphoblastic leukaemia: results of MRC UKALL X. Medical Research Council Working Party in Childhood Leukaemia.
по: Chessels, J, и др.
Опубликовано: (1997)

The Spectrum and Prognostic Relevance of Additional Abnormalities, Involving 12p and 21q, in Children with ETV6-RUNX1 Positive Acute Lymphoblastic Leukaemia (ALL)
по: Moorman, A, и др.
Опубликовано: (2008)

Adolescents with acute lymphoblastic leukaemia: outcome on UK national paediatric (ALL97) and adult (UKALLXII/E2993) trials.
по: Ramanujachar, R, и др.
Опубликовано: (2007)

Continuing (maintenance) therapy in lymphoblastic leukaemia: lessons from MRC UKALL X. Medical Research Council Working Party in Childhood Leukaemia.
по: Chessells, J, и др.
Опубликовано: (1997)